USPTO serial 50089187
LIPIDRESCUE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with LIPIDRESCUE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Chicago, IL, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Hillary E. Maynard
Hillary E. Maynard Polsinelli PCPO Box 140310Kansas City, MO 64114-0310United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and also including a medical syringe for administering the lipid emulsion, all for use in treating anesthetic and drug toxicity; Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and also including a medical syringe for administering the lipid emulsion, all for use in resuscitating patients; Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and also including a medical syringe for administering the lipid emulsion, all for use in treating cardiac arrest due to ischemia and cardiac failure; syringes that are used for administering lipid emulsions in the nature of syringes sold filled with a pharmaceutical, namely, a lipid emulsion for use in treating anesthetic and drug toxicity, treating neurological toxicity, treating cardiac arrest due to ischemia, treating cardiac failure, treating cardiac toxicity, and for resuscitating patients. | ACTIVE | — |
| 044 | Medical services, namely, treating anesthetic toxicity, treating drug overdoses and poisoning, resuscitating patients suffering from the toxic side effects caused by anesthetics and unknown substances, treating cardiac toxins, administering lipid emulsions and other lipid containing substances to patients, and administering lipid emulsions to treat cardiac arrest due to ischemia, cardiac failure, and cardiac toxicity | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 3, 2026 | NWAP | NEW APPLICATION ENTERED | — |